Clinical Trial Update: Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pregabalin for efficacy and safety in neuropathic pain associated with lumbo-sacral radiculopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Radiculopathy
• Radiculopathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Radiculopathy | Phase 3 | Status: COMPLETED